Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EBIT Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 93.14298.54-62.910.46-30.07

What is the latest EBIT Growth ratio of NATCO PHARMA ?

The latest EBIT Growth ratio of NATCO PHARMA is 93.14 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202493.14
Mar2023298.54
Mar2022-62.91
Mar20210.46
Mar2020-30.07

How is EBIT Growth of NATCO PHARMA Trending?

Years EBIT Growth % Change
Mar2024 93.14
-68.80
Mar2023 298.54
Positive
Mar2022 -62.91
Negative
Mar2021 0.46
Positive
Mar2020 -30.07 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,070.4 Cr -5.4% 2.3% -17.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,778.0 Cr 2.3% 5.6% 21.7% Stock Analytics
DIVIS LABORATORIES ₹161,949.0 Cr 1.5% 4.2% 51.2% Stock Analytics
CIPLA ₹123,222.0 Cr 0% 2.9% 10% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,205.0 Cr 0.6% 0.9% 23.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,707.7 Cr 0.8% 1.8% -5.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.4%

2.3%

-17.5%

SENSEX

0.9%

4.2%

8.3%


You may also like the below Video Courses